Actylis Acquires Pharm-RX
October 2024
Actylis has acquired Pharm-Rx, a leading distributor of specialty ingredients for the vitamin, mineral, supplement (VMS), and pharmaceutical industries. This acquisition strengthens Actylis' portfolio and positions it to deliver more innovative solutions to its customers, expanding its reach and expertise in the growing nutrition and OTC pharmaceutical markets. Pharm-Rx’s team will join Actylis to drive accelerated growth.
Technical paper brought to you by Actylis.
Supplements
Abbott to spin off US$8.5B Nutrition business behind Ensure and Similac
Abbott plans to separate its Nutrition business into an independent, publicly traded company. The new business is projected to deliver approximately US$8.5 billion in annual sales. Abbott’s Nutrition portfolio comprises global...
Supplements
Roquette backs pharma-grade excipients as OTC and consumer health converge
Roquette has spent this year unifying its health and pharmaceutical solutions team. The company notes that consumers expect higher quality from over-the-counter (OTC) products while innovative formats become popular as...
Supplements
CPHI Milan 2026: ADM backs stable postbiotics for stress, sleep & mood
At CPHI Milan 2026, ADM is discussing the advantages of postbiotics over probiotics, highlighting stability and formulation versatility across various formats. At the trade show in Italy, Nutrition Insight explores why...
